AGENDA
Content and faculty subject to change.
| MONDAY, FEBRUARY 20, 2017 | |
7:00-8:00 am | Registration & Continental Breakfast |
8:00-8:10 am | Welcome David H. Rubin, MD |
Module Topic 1: Neuroscience | |
8:10-8:30 am | Neurobiology of Addiction James A. Morrill, MD, PhD |
8:30-8:50 am | Genetics of Substance Use Disorders Robert R. Althoff, MD, PhD |
8:50-9:20 am | Panel Discussion Moderator: David H. Rubin, MD Panelists: James A. Morrill, MD, PhD; Robert R. Althoff, MD, PhD |
9:20-9:40 am | Coffee Break |
| Module Topic 2: Empirically Based Methodologies I |
9:40-10:00 am | Motivational Interviewing John F. Kelly, PhD |
10:00-10:20 am | CBT John F. Kelly, PhD |
10:20-10:40 am | Contingency Management Robert R. Althoff, MD, PhD |
10:40-11:20 am | Panel Discussion Moderator: Timothy E. Wilens, MD Panelists: John F. Kelly, PhD; Robert R. Althoff, MD, PhD |
| Module Topic 3: Developmental Perspectives |
11:20-11:40 am | Childhood Precursors Robert R. Althoff, MD, PhD |
11:40-12:00 pm | Adolescence Timothy E. Wilens, MD |
| 12:00-12:20 pm | Panel Discussion Moderator: David H. Rubin, MD Panelists: Robert R. Althoff, MD, PhD; Timothy E. Wilens, MD |
12:20-1:20 pm | Lunch |
| Module Topic 4: Pharmacotherapy I |
1:20-1:40 pm | Managing Complicated Withdrawal Shamim H. Nejad, MD |
1:40-2:00 pm | Nicotine James A. Morrill, MD, PhD |
2:00-2:20 pm | Methamphetamine, Cocaine, Stimulants Timothy E. Wilens, MD |
| 2:20-3:00 pm | Panel Discussion Moderator: Timothy E. Wilens, MD Panelists: Shamim H. Nejad, MD; James A. Morrill, MD, PhD |
3:00-3:20 pm | Coffee Break |
| Module Topic 5: Comorbidity I |
3:20-3:40 pm | Mood Disorders Shamim H. Nejad, MD |
3:40-4:00 pm | Hepatitis C / HIV James A. Morrill, MD, PhD |
4:00-4:20 pm | Anxiety Disorders Shamim H. Nejad, MD |
| 4:20-5:00 pm | Panel Discussion Moderator: Timothy E. Wilens, MD Panelists: Shamim H. Nejad, MD; James A. Morrill, MD, PhD |
| 5:00 pm | Adjourn |
| TUESDAY, FEBRUARY 21, 2017 | |
7:00-8:00 am | Continental Breakfast |
8:00-8:20 am | Introduction Timothy E. Wilens, MD |
Module Topic 6: Recovery Oriented Systems of Care | |
8:20-8:40 am | Recovery Models of Care John F. Kelly, PhD |
8:40-9:00 am | Treating Addiction as a Chronic Disease Sarah E. Wakeman, MD |
9:00-9:30 am | Panel Discussion Moderator: Timothy E. Wilens, MD Panelists:John F. Kelly, PhD; Sarah E. Wakeman, MD |
9:30-9:50 am | Coffee Break |
| Module Topic 7: Marijuana, Synthetics, and Triple C-Legal and Illegal |
9:50-10:10 am | Medical Marijuana Timothy E. Wilens, MD |
10:10-10:30 am | Management of Marijuana Addiction Martha T. Kane, PhD |
10:30-10:50 am | OCT: Synthetics and Triple-C Timothy E. Wilens, MD |
11:00 am-11:40 am | Panel Discussion Moderator: Laura G. Kehoe, MD, MPH Panelists: Timothy E. Wilens, MD; Martha T. Kane, PhD |
11:40-12:40 pm | Lunch |
| Module Topic 8: Empirically Based Methodologies II |
12:40-1:00 pm | Trauma Informed Care Martha T. Kane, PhD |
1:00-1:20 pm | Self-Help Treatments John F. Kelly, PhD |
1:20-1:50 pm | Panel Discussion Moderator: Laura G. Kehoe, MD, MPH Panelists: John F. Kelly, PhD; Martha T. Kane, PhD |
1:50-2:10 pm | Coffee Break |
| Module Topic 9: Comorbidity II |
2:10-2:30 pm | ADHD Timothy E. Wilens, MD |
2:30-2:50 pm | Pain Laura G. Kehoe, MD, MPH |
| 2:50-3:20 pm | Panel Discussion Moderator: Sarah E. Wakeman, MD Panelists: Timothy E. Wilens, MD; Laura G. Kehoe, MD, MPH |
3:20 pm | Adjourn |
| WEDNESDAY, FEBRUARY 22, 2017 | |
7:00-8:00 am | Continental Breakfast |
8:00-8:10 am | Introduction Sarah E. Wakeman, MD |
Module Topic 10: Inpatient | |
8:10-8:30 am | Substance Use Disorder Initiative: MGH Model Sarah E. Wakeman, MD |
8:30-8:50 am | Inpatient Nursing in Addiction Care Christopher J. Shaw, NP |
8:50-9:20 am | Panel Discussion Moderator: Laura G. Kehoe, MD, MPH Panelists: Christopher J. Shaw, NP; Sarah E. Wakeman, MD |
| Module Topic 11: Empirically Based Methodologies III |
9:20-9:40 am | Screening and Assessment Christopher J. Shaw, NP |
9:40-10:00 am | Harm Reduction Sarah E. Wakeman, MD |
10:00-10:30 am | Panel Discussion Moderator: Laura G. Kehoe, MD, MPH Panelists: Sarah E. Wakeman, MD; Christopher J. Shaw, NP |
| Module Topic 12: Pharmacotherapy II |
10:30-10:50 am
| Opioids Sarah E. Wakeman, MD |
10:50-11:10 am | Alcohol Laura G. Kehoe, MD, MPH |
11:10-11:30 am | Sedatives and Hypnotics Sarah E. Wakeman, MD |
11:30-12:10 pm | Panel Discussion Moderator: David H. Rubin, MD Panelists: Sarah E. Wakeman, MD; Laura G. Kehoe, MD, MPH |
12:10 pm | Adjourn |
